NC biotech center In 1981, a group of North Carolina legislators sat down to wrestle with a question that sounds almost naïve in retrospect: how do you build an industry that doesn't exist yet? The field of biotechnology was still largely theoretical — more petri dish than product line — and most American policymakers were content to watch the coastal research universities and their adjacent venture capital ecosystems take the lead. North Carolina's legislators took a different view. After commissioning a year-long study, they landed on an answer that was, frankly, unusual for the era: create a private, non-profit organization whose sole purpose was to grow biotechnology in the state. Not a government bureau. Not a university department. Something in between, and deliberately so. Three years later, in October 1984, the North Carolina Biotechnology Center (NCBiotech) opened in Research Triangle Park. It was, by most accounts, the world's first government-sponsored biotec...
Biotech Peptides: Tiny Molecules, Big Impact Peptides short chains of amino acids are emerging as powerful tools in modern biotechnology, offering vast potential in therapeutics, diagnostics, and industrial applications. Their ability to mimic natural biological processes while allowing precise structural and functional modifications makes them ideal candidates for next-generation biopharmaceuticals. In recent years, advancements in peptide synthesis, bioengineering, and delivery systems have opened new avenues in drug development, especially in areas like cancer treatment, metabolic disorders, and infectious diseases. Beyond healthcare, peptides are also being explored for use in agriculture, cosmetics, and material sciences. As research progresses, biotech peptides are proving to be essential components in bridging biology with innovative technological solutions. What Are Biotech Peptides? Peptides are tiny chains made from something called amino acids. You ...